what is gip and glp-1 receptors The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review Potential Use of GLP-1 and

This method eliminates the need for needles, making it an appealing option for those who may be uncomfortable with injections

Gonzlez-Mariscal I, Krzysik-Walker SM, Kim W, Rouse M, Egan JM

These are positive developments that will improve access and treatment persistence among patients needing obesity medications, particularly those covered by Medicare, state Medicaid programs in states that will choose to participate, and those who can afford the cash pay option. Meanwhile, he says, recognizing the primary reasons for discontinuation may facilitate more informed discussions between clinicians and their patients, helping to address challenges in long-term persistence with these highly effective medications. Horvath is a freelance writer based in Baltimore, Md

1

17.12 and 17.13) (Table 17.4) [1]

Inflammation of the pancreas is a known risk with all incretin-based medications